Quarter Calendar 2025 Printable – with NDA Submission on Track for 1H Calendar 2025 Projected Cash Runway into Second Calendar Quarter 2026 PRINCETON, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (Nasdaq: ACST . NDA submission to FDA for GTX-104 anticipated in the first half of calendar 2025. Conducted a meeting of STRIVE-ON trial investigators in April 2024. The Company reported a net loss of $2.6 million, .
Quarter Calendar 2025 Printable
Source : www.calendarpedia.com
Free 2025 Quarterly Calendar Templates CalendarLabs
Source : www.calendarlabs.com
Quarterly Calendars 2025 Free Printable PDF Templates
Source : www.calendarpedia.com
Download] Printable 2024 and 2025 Quarterly Calendars โ Lara Willard
Source : larawillard.com
Quarterly Calendars 2025 Free Printable Word Templates
Source : www.calendarpedia.com
Download] Printable 2024 and 2025 Quarterly Calendars โ Lara Willard
Source : larawillard.com
Quarterly Calendars 2025 Free Printable Word Templates
Source : www.calendarpedia.com
2025 Quarterly Calendar Printable Blank Dated Quarterly Year View
Source : www.etsy.com
Quarterly Calendars 2025 Free Printable Word Templates
Source : www.calendarpedia.com
Free 2025 Quarterly Calendar Templates CalendarLabs
Source : www.calendarlabs.com
Quarter Calendar 2025 Printable Quarterly Calendars 2025 Free Printable Word Templates: Revenue: CA$83.4m (up 11% from 1Q 2024). Net income: CA$6.22m (up from CA$20.8m loss in 1Q 2024). Profit margin: 7.5% (up from net loss in 1Q 2024). EPS: CA$0.12 (up from CA$0.59 loss in 1Q 2024 . First Fiscal Quarter 2025 Highlights Pivotal Phase 3 STRIVE-ON safety trial surpassed the 50% enrollment milestone. 100% patient enrollment of STRIVE-ON trial projected for late calendar 2024 or .